Anika Therapeutics (ANIK) Shares Outstanding (2016 - 2025)
Historic Shares Outstanding for Anika Therapeutics (ANIK) over the last 16 years, with Q3 2025 value amounting to $14.4 million.
- Anika Therapeutics' Shares Outstanding fell 185.79% to $14.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.4 million, marking a year-over-year decrease of 185.79%. This contributed to the annual value of $14.4 million for FY2024, which is 166.44% down from last year.
- Per Anika Therapeutics' latest filing, its Shares Outstanding stood at $14.4 million for Q3 2025, which was down 185.79% from $14.4 million recorded in Q2 2025.
- In the past 5 years, Anika Therapeutics' Shares Outstanding registered a high of $14.8 million during Q2 2024, and its lowest value of $14607.0 during Q3 2022.
- Its 5-year average for Shares Outstanding is $13.8 million, with a median of $14.5 million in 2022.
- Per our database at Business Quant, Anika Therapeutics' Shares Outstanding crashed by 9989.88% in 2022 and then skyrocketed by 10010538.1% in 2023.
- Anika Therapeutics' Shares Outstanding (Quarter) stood at $14.4 million in 2021, then grew by 1.27% to $14.6 million in 2022, then increased by 0.24% to $14.7 million in 2023, then dropped by 1.66% to $14.4 million in 2024, then grew by 0.03% to $14.4 million in 2025.
- Its last three reported values are $14.4 million in Q3 2025, $14.4 million for Q2 2025, and $14.3 million during Q1 2025.